Christine Cassiano | CCO |
David Chang | President and CEO |
Rafael Amado | EVP-Research and Development and CMO |
Eric Schmidt | CFO |
Salveen Richter | Goldman Sachs |
Marc Frahm | Cowen & Company |
Kelly Shi | Jefferies |
Michael Schmidt | Guggenheim |
John Newman | Canaccord |
Cory Kasimov | J.P. Morgan |
Luca Issi | RBC Capital |
Mark Breidenbach | Oppenheimer |
Ben Burnett | Stifel |
Dane Leone | Raymond James |
Randy Benjamin | JMP Securities |
Raju Prasad | William Blair |
Asthika Goonewardene | Truist Securities |
Good afternoon, ladies and gentlemen, thank you for standing by, and welcome to the Allogene Therapeutics First Quarter 2021 Conference Call. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference call is being recorded. I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms.